Peak6 Investments LLC Neurocrine Biosciences Inc Put Options Transaction History

Peak6 Investments LLC

14 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 13, 2024	SELL	$130.86 - $143.19 $981,450 - $1.07 Million	-7,500 Reduced 89.29%	900 $123,000
Q4 2023 Feb 13, 2024	BUY	$106.07 - $132.76 $880,381 - $1.1 Million	8,300 Added 8300.0%	8,400 $1.11 Million
Q3 2023 Nov 13, 2023	BUY	$94.02 - $117.1 $9,402 - $11,710	100 New	100 $11,000
Q1 2022 May 13, 2022	SELL	$72.45 - $94.81 $210,105 - $274,949	-2,900 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$86.18 - $99.03 $3.29 Million - $3.78 Million	-38,200 Reduced 92.94%	2,900 $278,000
Q3 2020 Nov 13, 2020	SELL	$96.16 - $135.15 $1.58 Million - $2.22 Million	-16,400 Reduced 28.52%	41,100 $3.95 Million
Q2 2020 Aug 14, 2020	SELL	$85.09 - $130.36 $1.24 Million - $1.9 Million	-14,600 Reduced 20.25%	57,500 $7.02 Million
Q1 2020 May 14, 2020	BUY	$75.11 - $113.76 $3.45 Million - $5.22 Million	45,900 Added 175.19%	72,100 $6.24 Million
Q4 2019 Feb 13, 2020	SELL	$86.8 - $118.57 $4.16 Million - $5.68 Million	-47,900 Reduced 64.64%	26,200 $2.82 Million
Q3 2019 Nov 08, 2019	BUY	$83.82 - $101.5 $1.13 Million - $1.37 Million	13,500 Added 22.28%	74,100 $6.68 Million
Q2 2019 Aug 14, 2019	SELL	$72.24 - $91.27 $3.32 Million - $4.2 Million	-46,000 Reduced 43.15%	60,600 $5.12 Million
Q1 2019 May 15, 2019	BUY	$69.31 - $91.53 $2.17 Million - $2.86 Million	31,300 Added 41.57%	106,600 $9.39 Million
Q4 2018 Feb 13, 2019	SELL	$68.32 - $124.36 $3.36 Million - $6.12 Million	-49,200 Reduced 39.52%	75,300 $5.38 Million
Q3 2018 Nov 13, 2018	BUY	$98.88 - $125.85 $12.3 Million - $15.7 Million	124,500 New	124,500 $15.3 Million

641

95.3M

661K

227K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.